Anaconda Biomed recently announced a $56 million funding round to advance what it describes as next-generation, novel thrombectomy catheters. The Barcelona-based company said the funds will support completion of the ongoing Athena pivotal IDE study, a prospective, randomized, 327-subject trial intended to evaluate the safety and performance of … [Read more...] about Anaconda Biomed brings in $56 million
Anaconda Biomed
Anaconda Biomed wins CE mark for funnel catheter
Anaconda Biomed announced today that it received CE mark approval to commercialize its ANA5 funnel catheter in Europe. The company designed ANA5, a next-generation funnel catheter, to optimize mechanical thrombectomy. It maximizes clot capture with its vessel-matching diameter funnel. Simultaneously, it enables antegrade flow arrest and offers the … [Read more...] about Anaconda Biomed wins CE mark for funnel catheter
Anaconda Biomed enrolls first patient in study of funnel catheter for treating stroke
Anaconda Biomed announced the enrollment and treatment of the first U.S. patient in a clinical trial of its ANA Funnel Catheter. Dr. Shahram Majidi performed the first treatment in the ATHENA trial at Mount Sinai in New York. The 327-patient study evaluates the safety and effectiveness of the proprietary funnel catheter. Anaconda designed the … [Read more...] about Anaconda Biomed enrolls first patient in study of funnel catheter for treating stroke
